175 related articles for article (PubMed ID: 23633920)
1. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
Mohammed A; Janakiram NB; Brewer M; Vedala K; Steele VE; Rao CV
Neoplasia; 2013 May; 15(5):481-90. PubMed ID: 23633920
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
Mohammed A; Janakiram NB; Li Q; Choi CI; Zhang Y; Steele VE; Rao CV
Cancer Prev Res (Phila); 2011 Dec; 4(12):2015-26. PubMed ID: 21885812
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
Ravillah D; Mohammed A; Qian L; Brewer M; Zhang Y; Biddick L; Steele VE; Rao CV
J Pharmacol Exp Ther; 2014 Jan; 348(1):59-68. PubMed ID: 24218540
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.
Benbrook DM; Guruswamy S; Wang Y; Sun Z; Mohammed A; Zhang Y; Li Q; Rao CV
Cancer Prev Res (Phila); 2013 Sep; 6(9):908-16. PubMed ID: 23852423
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R
Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
10. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
[TBL] [Abstract][Full Text] [Related]
11. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Wu X; Song M; Qiu P; Rakariyatham K; Li F; Gao Z; Cai X; Wang M; Xu F; Zheng J; Xiao H
Carcinogenesis; 2017 Apr; 38(4):455-464. PubMed ID: 28207072
[TBL] [Abstract][Full Text] [Related]
12. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-β expression in Apc-driven colorectal carcinogenesis.
Luceri C; Femia AP; Tortora K; D'Ambrosio M; Fabbri S; Fazi M; Caderni G
Eur J Cancer Prev; 2020 Jan; 29(1):27-35. PubMed ID: 31651566
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.
Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV
Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924
[TBL] [Abstract][Full Text] [Related]
15. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
[TBL] [Abstract][Full Text] [Related]
16. Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ω-3 fatty acid rich perilla oil.
Rao CV; Patlolla JM; Cooma I; Kawamori T; Steele VE
Nutr Cancer; 2013; 65 Suppl 1():54-60. PubMed ID: 23682783
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
Janakiram NB; Mohammed A; Brewer M; Bryant T; Biddick L; Lightfoot S; Pathuri G; Gali H; Rao CV
Cancer Prev Res (Phila); 2014 Mar; 7(3):300-9. PubMed ID: 24431404
[TBL] [Abstract][Full Text] [Related]
19. The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models.
Chandrasekaran B; Pal D; Kolluru V; Tyagi A; Baby B; Dahiya NR; Youssef K; Alatassi H; Ankem MK; Sharma AK; Damodaran C
Carcinogenesis; 2018 Dec; 39(12):1537-1547. PubMed ID: 30124785
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
